The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 2,753 | 24,700 | SH | SOLE | 24,700 | 0 | 0 | ||
| BLACKSTONE MTG TR INC | COM CL A | 09257W100 | 3,906 | 124,300 | SH | SOLE | 124,300 | 0 | 0 | ||
| FGL HLDGS | ORD SHS | G3402M102 | 15,225 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| FGL HLDGS | *W EXP 11/30/202 | G3402M110 | 1,365 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| ISHARES TR | FLTG RATE NT ETF | 46429B655 | 24,462 | 480,315 | SH | SOLE | 480,315 | 0 | 0 | ||
| KKR REAL ESTATE FIN TR INC | COM | 48251K100 | 4,622 | 230,391 | SH | SOLE | 230,391 | 0 | 0 | ||
| MELINTA THERAPEUTICS INC | COM | 58549G100 | 64,598 | 8,729,459 | SH | SOLE | 8,729,459 | 0 | 0 | ||
| SHIRE PLC | SPONSORED ADR | 82481R106 | 9,359 | 62,650 | SH | SOLE | 62,650 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 496 | 182,395 | SH | SOLE | 182,395 | 0 | 0 | ||